Session Details

Moderator

Carlos L Arteaga, UT Southwestern Medical Center, Dallas, TX

Presentation numberAL4-01

Repurposing driver and clonal fusion RNAs as therapeutic vulnerabilities with a programmable nucleic acid sensing system

Nolan Priedigkeit, Dana-Farber Cancer Institute / Broad Institute, Boston, MA

Presentation numberAL4-02

Digital Histology Models Predict Chemotherapy Benefit in Randomized Adjuvant Trials and Real-World Cohorts

Frederick Howard, UChicago Medicine, Chicago, IL